Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Cancer|July 25, 2003
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinomaJeffrey A Meyerhardt, Paul J Catalano, Daniel G Haller, et al.
Cancer|July 19, 2006
Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancerHoward S Hochster, Daniel G Haller, Aimery de Gramont, et al.
Genes, Chromosomes & Cancer|September 16, 2017
Extreme chromosome 17 copy number instability is a prognostic factor in patients with gastroesophageal adenocarcinoma: A retrospective cohort studyJacqueline E Birkness, Neal G Spada, Caitlyn Miller, et al.
Journal of Clinical Medicine|October 17, 2020
Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic CancerJessica Allen, Colin Cernik, Suhaib Bajwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodesAdam C Berger, Elin R Sigurdson, Thomas LeVoyer, et al.
Journal of Medicinal Food|June 1, 2018
Schisantherin A Improves Learning and Memory of Mice with D-Galactose-Induced Learning and Memory Impairment Through Its Antioxidation and Regulation of p19/p53/p21/Cyclin D1/CDK4/RB Gene ExpressionsCong Liu, Weijing Sun, Ning Li, et al.
Annals of Surgical Oncology|April 8, 2003
Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resectionNatalie E Joseph, Elin R Sigurdson, Alexandra L Hanlon, et al.
BMC Cancer|June 5, 2020
Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations: a Meta-analysis and systematic reviewGhulam Rehman Mohyuddin, Muhammad Aziz, Alec Britt, et al.
Journal of Gastrointestinal Oncology|July 25, 2017
Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer-retrospective analysis of responseKhanh T Nguyen, Aparna Kalyan, H Scott Beasley, et al.
British Journal of Clinical Pharmacology|January 11, 2019
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairmentMuhammad Wasif Saif, Lee Rosen, Michelle A Rudek, et al.
Pageof 21